ANTIBODIES loaded with radioactive isotopes have completely banished tumours
in scores of patients with a fatal form of the blood cancer non-Hodgkin’s
lymphoma. Tumours shrank in 74 of the 76 patients receiving the antibodies and,
three or more years after treatment, were undetectable in 58
patients—three-quarters of those treated.
Mark Kaminski and Richard Wahl of the University of Michigan Comprehensive
Cancer Center in Ann Arbor reported their findings last month at a meeting of
the American Society of Clinical Oncology in New Orleans. “The tumours continued
to shrink after therapy,” says Wahl. “We saw complete remissions within
months.”
The…
